ArticleHuman cell2024

Tracking circulating PD-L1-positive cells to monitor the outcome of patients with gastric cancer receiving anti-HER2 plus anti-PD-1 therapy.

Xiaoyi Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.